Companion Animal Diagnostics Segmentation
The market is segmented on the basis of technology which is further bifurcated into immunodiagnostics, clinical biochemistry, haematology, urinalysis, molecular diagnosis, and, others, out of which the molecular diagnosis segment is anticipated to hold the largest share in the target market as compared to other technologies. As the need for reliable, specific, and faster methods to detect chronic diseases and genetic disorders in the primary stage is growing, it has led to the growth of the market segment.
On the basis of application, clinical pathology segment in the global companion animal disease diagnostics market is projected to grow with a significant CAGR over the forecast period. The market is growing because clinical pathology tests are considered as the first tool for the evaluation of disease patterns as it provides an understanding of disease mechanism and progression as it is important for the development of new treatments.
Our in-depth analysis of the global market includes the following segments:
|
By Technology |
|
|
By Application |
|
|
By Animal Type |
|
|
End-User |
|
